Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05981131 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Muscle Invasive Bladder Cancer

Interventions

DRUG: N803 plus Bacillus Calmette-Guerin (BCG)

Sponsor

ImmunityBio, Inc.